Released Aug 6, 2018, after the close
10-Q filed Aug 6, 2018, 37 days after period end · 0001558370-18-006445
Q2 2018 · 10-Q
Revenue$81.11M$81.11M +24.6% vs Q2 2017+17.3% vs Q1 2018
Net Income-$49.38M-$49.38M N/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.32-$0.32 N/M vs Q2 2017N/M vs Q1 2018
Operating Income-$14,677,000N/M
Operating Cash Flowderived-$22,691,000N/M
Free Cash Flowderived-$22,629,000N/M
Margins · derived
Operating margin-18.1%+44.9 pt vs Q2 2017
Net margin-60.9%+7.1 pt vs Q2 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $81.11M | $65.08M | $54.35M | $27.74M |
| Net Income | -$49.38M | -$44.22M | -$21.70M | — |
| EPS Diluted | -$0.32 | -$0.30 | -$0.15 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR